Lv11
10 积分 2021-03-14 加入
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
55分钟前
待确认
Efficacy and safety of MIL62, a novel glycoengineered type Ⅱ anti-CD20 monoclonal antibody, combined with lenalidomide in patients with relapsed/refractory follicular lymphoma or marginal zone lymphoma: a multicentre, single-arm, phase 1b/2 trial
2天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
5个月前
已完结
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial
5个月前
已完结
Initiation of renin–angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study
5个月前
已完结
Updated diagnostic and therapeutic management for membranous nephropathy
5个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
8个月前
已完结
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
8个月前
已完结
Emerging therapeutics in the management of connective tissue disease. Part I. Lupus erythematosus and Sjögren syndrome
9个月前
已完结
Blood eosinophil count in the diagnosis of allergic‐like rhinitis with chronic rhinosinusitis
9个月前
已完结
皖公网安备34019202002308
